232
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Content comparison of guideline-recommended instruments used in treatment for alcohol use disorders

, &
Pages 1682-1689 | Received 19 Jun 2017, Accepted 24 Jan 2018, Published online: 04 Feb 2018

References

  • Levola J, Kaskela T, Holopainen A, et al. Psychosocial difficulties in alcohol dependence: a systematic review of activity limitations and participation restrictions. Disabil Rehabil. 2014;36:1227–1239.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing; 2013.
  • World Health Organization. International classification of diseases and related health problems, 10th Revision (ICD-10). Geneva: WHO; 1992.
  • Foster JH, Powell JE, Marshall EJ, et al. Quality of life in alcohol-dependent subjects – a review. Qual Life Res. 1999;8:255–261.
  • National Institute for Health and Care Excellence. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. London: National Institute for Health and Clinical Excellence; 2011. (NICE clinical guideline 115).
  • Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen [S3-guideline ’screening, diagnosis and treatment of alcohol use disorders’]. Heidelberg: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; 2015. (AWMF-Register Nr. 076-001).
  • Deady M. A review of screening, assessment and outcome measures for drug and alcohol settings. New South Wales, Australia: Network of Alcohol and Other Drugs Agencies; 2009
  • Finney JW, Moyer A, Swearingen CE. Outcome variables and their assessment in alcohol treatment studies: 1968-1998. Alcohol. Clin Exp Res. 2003;27:1671–1679.
  • Tiffany ST, Friedman L, Greenfield SF, et al. Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction. 2012;107:709–718.
  • McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168:26–33.
  • Schippers GM, Broekman TG, Buchholz A, et al. Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications. Addiction. 2010;105:862–871.
  • Spies M, Maschler C, Buchholz A. Teilhabeeinschränkungen bei Suchterkrankungen. Bundesgesundheitsbl. 2016;59:1154–1161.
  • Rehm J, Marmet S, Anderson P, et al. Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol. 2013;48:633–640.
  • World Health Organization. ICF: International classification of functioning, disability and health. Geneva: WHO; 2001.
  • Brütt AL, Schulz H, Koch U, et al. Do measures used in studies of anxiety disorders reflect activities and participation as defined in the WHO International Classification of Functioning, Disability and Health?. Clin Rehabil. 2011;25:659–671.
  • Cieza A, Geyh S, Chatterji S, et al. ICF linking rules: an update based on lessons learned. J Rehabil Med. 2005;37:212–218.
  • Fayed N, Cieza A, Bickenbach JE. Linking health and health-related information to the ICF: a systematic review of the literature from 2001 to 2008. Disabil Rehabil. 2011;33:1941–1951.
  • Cieza A, Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Qual Life Res. 2005;14:1225–1237.
  • Weigl M, Cieza A, Harder M, et al. Linking osteoarthritis-specific health-status measures to the International Classification of Functioning, Disability, and Health (ICF). Osteoarthr 2003;11:519–523.
  • Brockow T, Wohlfahrt K, Hillert A, et al. Identifying the concepts contained in outcome measures of clinical trials on depressive disorders using the International Classification of Functioning, Disability and Health as a reference. J Rehabil Med. 2004;44(Suppl):49–55.
  • National Health and Medical Research Council. Australian guidelines to reduce health risks from drinking alcohol. Canberra: National Health and Medical Research Council; 2009.
  • British Columbia Medical Association. Problem drinking part 1 - screening and assessment (revised version). Vancouver, BC: British Columbia Medical Association; 2013.
  • Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Riskanter schädlicher und abhängiger Alkoholkonsum: Screening, Diagnostik, Kurzintervention. Leitlinien der AWMF. Düsseldorf: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; 2004. (AWMF-Register Nr. 076/003).
  • Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. AWMF-Behandlungsleitlinie: Akutbehandlung alkoholbezogener Störungen [Acute treatment of alcohol use disorders]. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; 2003. (AWMF-Register Nr. 076/001).
  • Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Postakutbehandlung alkoholbezogener Störungen. Leitlinien der AWMF [Postacute treatment of alcohol abuse and dependence]. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; 2003. (AWMF-Register Nr. 076/008).
  • New Zealand Ministry of Health. Service delivery for people with co-existing mental health and addiction problems: integrated solutions. Wellington: New Zealand Ministry of Health; 2010. (www.moh.govt.nz)
  • National Institute for Clinical Excellence. Alcohol-use disorders: preventing harmful drinking. London: National Institute for Clinical Excellence; 2010. (NICE public health guidance 24).
  • National Institute for Health and Care Excellence. Alcohol-use disorders: diagnosis and clinical management of alcohol-related physical complications. London: National Institute for Health and Care Excellence; 2010. (NICE clinical guideline 100).
  • Department of Health (England) and the devolved administrations. Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England) and the devolved administrations; 2007.
  • American Psychiatric Association. Practice guidelines for the treatment of psychiatric disorders: compendium 2006. Lake St. Louis (MO): American Psychiatric Association; 2006.
  • U.S. Preventive Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2013;159:210–8.
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174.
  • Oner FC, Jacobs WCH, Lehr AM, et al. Toward the development of a universal outcome instrument for spine Trauma: a systematic review and content comparison of outcome measures used in spine trauma research using the ICF as reference. Spine (Phila PA 1976). 2016;41:358–367.
  • Geyh S, Cieza A, Kollerits B, et al. Content comparison of health-related quality of life measures used in stroke based on the international classification of functioning, disability and health (ICF): a systematic review. Qual Life Res. 2007;16:833–851.
  • Valdes K, Naughton N, Algar L. Linking ICF components to outcome measures for orthotic intervention for CMC OA: a systematic review. J Hand Ther. 2016;29:396–404.
  • Schuckit MA. Alcohol-use disorders. Lancet. 2009;373:492–501.
  • Buchholz A, Spies M, Brütt AL. ICF-basierte Messinstrumente zur Bedarfserfassung und Evaluation in der Behandlung von Patienten mit psychischen Störungen – ein systematisches review [ICF-based assessments to evaluate need and success in the treatment of patients with mental disorders]. Die Rehabilitation. 2015;54:153–159.
  • Pösl M, Cieza A, Stucki G. Psychometric properties of the WHODASII in rehabilitation patients. Qual Life Res. 2007;16:1521–1531.
  • Raistrick D, Bradshaw J, Tober G, et al. Development of the Leeds dependence questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction. 1994;89:563–572.
  • Raistrick D, Dunbar G, Davidson R. Development of a questionnaire to measure alcohol dependence. Addiction. 1983;78:89–95.
  • Miller WR, Tonigan JS. Assessing drinkers’ motivation for change: the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychol Addict Behav. 1996;10:81–89.
  • Stockwell T, Hodgson R, Edwards G, et al. The development of a questionnaire to measure severity of alcohol dependence. Addiction. 1979;74:79–87.
  • Deering D, Robinson G, Wheeler A, et al. Preliminary work towards validating a draft outcome measure for use in the alcohol and drug sector. Auckland: Te Pou o te Whakaaro Nui (National Centre of Mental Health Research, Information and Workforce Development); 2009.
  • John U, Hapke U, Rumpf H-J. A new measure of the alcohol dependence syndrome: the Severity Scale of Alcohol Dependence. Eur Addict Res. 2003;9:87–93.
  • Williams BTR, Drummond DC. The Alcohol Problems Questionnaire: reliability and validity. Drug Alcohol Depend. 1994;35:239–243.
  • Miele GM, Carpenter KM, Smith Cockerham M, et al. Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. Drug Alcohol Depend. 2000;59:63–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.